These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 35648773)

  • 21. Seroprevalence and risk factors of hepatitis E virus infection among children in China.
    Meng QF; You HL; Wang WL; Zhou N; Dong W; Cong W
    J Med Virol; 2015 Sep; 87(9):1573-7. PubMed ID: 25940435
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatitis E seroprevalence and risk factors in humans and pig in Ghana.
    Bagulo H; Majekodunmi AO; Welburn SC; Bimi L
    BMC Infect Dis; 2022 Feb; 22(1):132. PubMed ID: 35130864
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatitis E seroprevalence in the United States: Results for immunoglobulins IGG and IGM.
    Cangin C; Focht B; Harris R; Strunk JA
    J Med Virol; 2019 Jan; 91(1):124-131. PubMed ID: 30168589
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Seroprevalence and molecular characteristics of hepatitis E virus in household-raised pig population in the Philippines.
    Liu X; Saito M; Sayama Y; Suzuki E; Malbas FF; Galang HO; Furuse Y; Saito M; Li T; Suzuki A; Oshitani H
    BMC Vet Res; 2015 Jan; 11():11. PubMed ID: 25622684
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Special Risk Group for Hepatitis E Infection: The First Record of North Cyprus.
    Süer K; Güvenir M; Aykaç A
    Pol J Microbiol; 2018; 67(4):525-528. PubMed ID: 30550239
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Seroprevalence of Hepatitis E Virus in Iran: A Systematic Review and Meta-analysis.
    Behzadifar M; Lankarani KB; Abdi S; Taheri Mirghaed M; Beyranvand G; Keshavarzi A; Ghoreishinia G; Rezapour A; Behzadifar M
    Middle East J Dig Dis; 2016 Jul; 8(3):189-200. PubMed ID: 27698968
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hepatitis E virus exposure in pregnant women in rural Durango, Mexico.
    Alvarado-Esquivel C; Sánchez-Anguiano LF; Hernández-Tinoco J
    Ann Hepatol; 2014; 13(5):510-7. PubMed ID: 25152983
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Systematic review of global hepatitis E outbreaks to inform response and coordination initiatives.
    Al-Shimari FH; Rencken CA; Kirkwood CD; Kumar R; Vannice KS; Stewart BT
    BMC Public Health; 2023 Jun; 23(1):1120. PubMed ID: 37308896
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High seroprevalence of hepatitis E among pigs suggests an animal reservoir in Cameroon.
    Modiyinji AF; Atsama MA; Monamele GC; Nola M; Njouom R
    J Infect Dev Ctries; 2018 Aug; 12(8):676-679. PubMed ID: 31958332
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Nationwide Survey of the Seroprevalence of Hepatitis E Virus Infections Among Blood Donors in Thailand.
    Jupattanasin S; Chainuvati S; Chotiyaputta W; Chanmanee T; Supapueng O; Charoonruangrit U; Oota S; Louisirirotchanakul S
    Viral Immunol; 2019 Sep; 32(7):302-307. PubMed ID: 31403386
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Seroprevalence of hepatitis E virus among pregnant women and control subjects in China.
    Cong W; Sui JC; Zhang XY; Qian AD; Chen J; Zhu XQ
    J Med Virol; 2015 Mar; 87(3):446-50. PubMed ID: 25164987
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Seroprevalence of hepatitis E virus differs in Dutch and first generation migrant populations in Amsterdam, the Netherlands: a cross-sectional study.
    Sadik S; van Rijckevorsel GG; van Rooijen MS; Sonder GJ; Bruisten SM
    BMC Infect Dis; 2016 Nov; 16(1):659. PubMed ID: 27825308
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hepatitis E Virus Seroprevalence and Correlates of Anti-HEV IgG Antibodies in the Rakai District, Uganda.
    Boon D; Redd AD; Laeyendecker O; Engle RE; Nguyen H; Ocama P; Boaz I; Ndyanabo A; Kiggundu V; Reynolds SJ; Gray RH; Wawer MJ; Purcell RH; Kirk GD; Quinn TC; Stabinski L;
    J Infect Dis; 2018 Feb; 217(5):785-789. PubMed ID: 29186448
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High prevalence of anti-hepatitis E virus antibodies in outpatients with chronic liver disease in a university medical center in Germany.
    Schulz M; Beha D; Plehm K; Zöllner C; Hofmann J; Schott E
    Eur J Gastroenterol Hepatol; 2016 Dec; 28(12):1431-1436. PubMed ID: 27552296
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Seroprevalence and risk factors of hepatitis E virus infection in cancer patients in eastern China.
    Bai MJ; Zhou N; Dong W; Li GX; Cong W; Zhu XQ
    Int J Infect Dis; 2018 Jun; 71():42-47. PubMed ID: 29656134
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Seroprevalence of hepatitis E virus (HEV) in a general adult population in Northern Norway: the Tromsø study.
    Olsøy IB; Henriksen S; Weissbach FH; Larsen M; Borgen K; Abravanel F; Kamar N; Paulssen EJ; Hirsch HH; Rinaldo CH
    Med Microbiol Immunol; 2019 Dec; 208(6):715-725. PubMed ID: 30903372
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatitis E Virus: A Cross-Sectional Serological and Virological Study in Pigs and Humans at Zoonotic Risk within a High-Density Pig Farming Area.
    Caruso C; Peletto S; Rosamilia A; Modesto P; Chiavacci L; Sona B; Balsamelli F; Ghisetti V; Acutis PL; Pezzoni G; Brocchi E; Vitale N; Masoero L
    Transbound Emerg Dis; 2017 Oct; 64(5):1443-1453. PubMed ID: 27380833
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Age-related and regional differences in the prevalence of hepatitis E virus-specific antibodies in pigs in Germany.
    Krumbholz A; Joel S; Neubert A; Dremsek P; Dürrwald R; Johne R; Hlinak A; Walther M; Lange J; Wutzler P; Sauerbrei A; Ulrich RG; Zell R
    Vet Microbiol; 2013 Dec; 167(3-4):394-402. PubMed ID: 24238666
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The study of seroprevalence of hepatitis E virus and an investigation into the lifestyle behaviours of the aborigines in Malaysia.
    Wong LP; Alias H; Choy SH; Goh XT; Lee SC; Lim YAL; Kee BP; Chua KH; Kamaruzaman A; Zheng Z; Zhao Q; Wu T
    Zoonoses Public Health; 2020 May; 67(3):263-270. PubMed ID: 31927794
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Low prevalence of anti-hepatitis E virus IgG antibodies in Tepehuanos in Mexico.
    Alvarado-Esquivel C; Gutierrez-Martinez VD; Ramírez-Valles EG; Sifuentes-Alvarez A
    Ann Hepatol; 2020; 19(2):186-189. PubMed ID: 31771821
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.